Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases.

Gril B, Paranjape AN, Woditschka S, Hua E, Dolan EL, Hanson J, Wu X, Kloc W, Izycka-Swieszewska E, Duchnowska R, Pęksa R, Biernat W, Jassem J, Nayyar N, Brastianos PK, Hall OM, Peer CJ, Figg WD, Pauly GT, Robinson C, Difilippantonio S, Bialecki E, Metellus P, Schneider JP, Steeg PS.

Nat Commun. 2018 Jul 13;9(1):2705. doi: 10.1038/s41467-018-05030-w.

2.

Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.

Czapiewski P, Kunc M, Gorczyński A, Haybaeck J, Okoń K, Reszec J, Lewczuk A, Dzierzanowski J, Karczewska J, Biernat W, Turri-Zanoni M, Castelnuovo P, Taverna C, Franchi A, La Rosa S, Sessa F, Klöppel G.

Hum Pathol. 2018 May 25. pii: S0046-8177(18)30179-5. doi: 10.1016/j.humpath.2018.05.013. [Epub ahead of print]

PMID:
29807052
3.

Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?

Kunc M, Biernat W, Senkus-Konefka E.

Cancer Treat Rev. 2018 Jun;67:78-87. doi: 10.1016/j.ctrv.2018.05.005. Epub 2018 May 16. Review.

PMID:
29772460
4.

Clinicopathologic retrospective analysis of blastic plasmacytoid dendritic cell neoplasms.

Owczarczyk-Saczonek A, Sokołowska-Wojdyło M, Olszewska B, Malek M, Znajewska-Pander A, Kowalczyk A, Biernat W, Poniatowska-Broniek G, Knopińska-Posłuszny W, Kozielec Z, Nowicki R, Placek W.

Postepy Dermatol Alergol. 2018 Apr;35(2):128-138. doi: 10.5114/ada.2017.72269. Epub 2018 Apr 24. Review.

5.

Transient improvement of skin symptoms in an adult patient with pediatric-onset cutaneous mastocytosis treated with interferon-α.

Czarny J, Lange M, Niedoszytko M, Biernat W, Ługowska-Umer H, Wasąg B, Lewandowski K, Nowicki R.

Int J Dermatol. 2018 Apr 6. doi: 10.1111/ijd.13965. [Epub ahead of print] No abstract available.

PMID:
29633240
6.

The first case of drug-induced pseudoscleroderma and eczema craquelé related to nab-paclitaxel pancreatic adenocarcinoma treatment.

Sokołowska-Wojdyło M, Kłudkowska J, Olszewska B, Seredyńska J, Biernat W, Błażewicz I, Rustowska-Rogowska A, Nowicki RJ.

Postepy Dermatol Alergol. 2018 Feb;35(1):106-108. doi: 10.5114/pdia.2017.67054. Epub 2018 Feb 20. No abstract available.

7.

Consensus statement on a screening programme for the detection of early lung cancer in Poland.

Rzyman W, Didkowska J, Dziedzic R, Grodzki T, Orłowski T, Szurowska E, Langfort R, Biernat W, Kowalski D, Dyszkiewicz W, Jędrzejczyk T, Zdrojewski T, Nawrocki S, Jassem E, Adamek M.

Adv Respir Med. 2018;86(1):53-74. doi: 10.5603/ARM.2018.0009.

8.

Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.

Chłopik A, Selim MA, Peng Y, Wu CL, Tell-Marti G, Paral KM, Shalin SC, Kraft S, Hsu CK, Shea CR, Puig S, Fernandez-Figueras MT, Biernat W, Ryś J, Marszalek A, Hoang MP.

Hum Pathol. 2018 Mar;73:176-183. doi: 10.1016/j.humpath.2017.12.022. Epub 2018 Jan 4.

PMID:
29307625
9.

Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab.

Duchnowska R, Sperinde J, Czartoryska-Arłukowicz B, Myśliwiec P, Winslow J, Radecka B, Petropoulos C, Demlova R, Orlikowska M, Kowalczyk A, Lang I, Ziółkowska B, Dębska-Szmich S, Merdalska M, Grela-Wojewoda A, Żawrocki A, Biernat W, Huang W, Jassem J.

Oncotarget. 2017 Oct 24;8(61):104149-104159. doi: 10.18632/oncotarget.22027. eCollection 2017 Nov 28.

10.

Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer.

Ratajska M, Koczkowska M, Żuk M, Gorczyński A, Kuźniacka A, Stukan M, Biernat W, Limon J, Wasąg B.

Oncotarget. 2017 Sep 8;8(60):101325-101332. doi: 10.18632/oncotarget.20722. eCollection 2017 Nov 24.

11.

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.

Kerr KM, Dafni U, Schulze K, Thunnissen E, Bubendorf L, Hager H, Finn S, Biernat W, Vliegen L, Losa JH, Marchetti A, Cheney R, Warth A, Speel EJ, Blackhall F, Monkhorst K, Jantus Lewintre E, Tischler V, Clark C, Bertran-Alamillo J, Meldgaard P, Gately K, Wrona A, Vandenberghe P, Felip E, De Luca G, Savic S, Muley T, Smit EF, Dingemans AC, Priest L, Baas P, Camps C, Weder W, Polydoropoulou V, Geiger TR, Kammler R, Sumiyoshi T, Molina MA, Shames DS, Stahel RA, Peters S; ETOP Lungscape Consortium.

Ann Oncol. 2018 Jan 1;29(1):200-208. doi: 10.1093/annonc/mdx629.

PMID:
29186353
12.

PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients.

Sznurkowski JJ, Żawrocki A, Sznurkowska K, Pęksa R, Biernat W.

Oncotarget. 2017 Sep 15;8(52):89903-89912. doi: 10.18632/oncotarget.20911. eCollection 2017 Oct 27.

13.

Primary Ewing Sarcoma of the Thyroid-Eight Cases in a Decade: A Case Report and Literature Review.

Kabata P, Kaniuka-Jakubowska S, Kabata W, Lakomy J, Biernat W, Sworczak K, Jaśkiewicz J, Świerblewski M.

Front Endocrinol (Lausanne). 2017 Oct 27;8:257. doi: 10.3389/fendo.2017.00257. eCollection 2017.

14.

Acanthoma planoepitheliale hyperkeratoticum, lesions associated with BRAF inhibitor in metastatic melanoma.

Sokołowska-Wojdyło M, Olszewska B, Sobjanek M, Sławińska M, Sosińska-Mielcarek K, Biernat W, Nowicki R.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e83-e84. doi: 10.1111/jdv.14540. Epub 2017 Sep 22. No abstract available.

PMID:
28857272
15.

Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low-Microbial Content Samples.

Clarke EL, Lauder AP, Hofstaedter CE, Hwang Y, Fitzgerald AS, Imai I, Biernat W, Rękawiecki B, Majewska H, Dubaniewicz A, Litzky LA, Feldman MD, Bittinger K, Rossman MD, Patterson KC, Bushman FD, Collman RG.

Am J Respir Crit Care Med. 2018 Jan 15;197(2):225-234. doi: 10.1164/rccm.201705-0891OC.

PMID:
28846439
16.

Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.

Inaguma S, Lasota J, Wang Z, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Ikeda H, Schrump DS, Hassan R, Miettinen M.

Hum Pathol. 2018 Jan;71:1-7. doi: 10.1016/j.humpath.2017.04.032. Epub 2017 Aug 12.

PMID:
28811252
17.

KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas.

Dias-Santagata D, Selim MA, Su Y, Peng Y, Vollmer R, Chłopik A, Tell-Marti G, Paral KM, Shalin SC, Shea CR, Puig S, Fernandez-Figueras MT, Biernat W, Ryś J, Marszalek A, Hoang MP.

Br J Dermatol. 2017 Nov;177(5):1376-1384. doi: 10.1111/bjd.15836. Epub 2017 Nov 5. Erratum in: Br J Dermatol. 2018 Mar;178(3):815.

PMID:
28734009
18.

Langerhans cell histiocytosis followed by folliculotropic mycosis fungoides.

Błażewicz I, Sokołowska-Wojdyło M, Piekarska A, Sadowska-Klasa A, Kowalczyk A, Konczalska M, Olszewska B, Barańska-Rybak W, Biernat W, Nowicki RJ.

Postepy Dermatol Alergol. 2017 Jun;34(3):273-275. doi: 10.5114/pdia.2017.67055. Epub 2017 May 29. No abstract available.

19.

Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma.

Sznurkowski JJ, Żawrocki A, Biernat W.

Oncotarget. 2017 Jul 11;8(28):46204-46210. doi: 10.18632/oncotarget.17581.

20.

Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma.

Inaguma S, Wang Z, Lasota J, Onda M, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Ikeda H, Schrump DS, Hassan R, Pastan I, Miettinen M.

Oncotarget. 2017 Apr 18;8(16):26744-26754. doi: 10.18632/oncotarget.15814.

21.

SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma.

Lasota J, Kowalik A, Felisiak-Golabek A, Inaguma S, Wang ZF, Pięciak L, Zięba S, Pęksa R, Kopczynski J, Okoń K, Waloszczyk P, Gozdz S, Biernat W, Miettinen M.

Arch Pathol Lab Med. 2017 Apr;141(4):564-568. doi: 10.5858/arpa.2016-0147-OA. Epub 2017 Feb 28.

PMID:
28353383
22.

Application of high-resolution genomic profiling in the differential diagnosis of liposarcoma.

Koczkowska M, Lipska-Ziętkiewicz BS, Iliszko M, Ryś J, Miettinen M, Lasota J, Biernat W, Harazin-Lechowska A, Kruczak A, Limon J.

Mol Cytogenet. 2017 Mar 16;10:7. doi: 10.1186/s13039-017-0309-5. eCollection 2017.

23.

IgG4‑related disease as an unusual cause of biliary stenosis and lymphadenopathy.

Stojek M, Rymkiewicz G, Smoczyński M, Biernat W, Adrych K, Zaucha JM.

Pol Arch Intern Med. 2017 Mar 21;127(3):212-213. doi: 10.20452/pamw.3983. Epub 2017 Mar 21. No abstract available.

24.

Geringes Ansprechen disseminierter eruptiver Syringome auf systemische Behandlung mit Acitretin.

Stawczyk-Macieja M, Szczerkowska-Dobosz A, Błażewicz I, Nowicki R, Biernat W.

J Dtsch Dermatol Ges. 2017 Mar;15(3):325-326. doi: 10.1111/ddg.12800_g. No abstract available.

PMID:
28252844
25.

Generalized eruptive syringoma with poor clinical response to systemic treatment with acitretin.

Stawczyk-Macieja M, Szczerkowska-Dobosz A, Błażewicz I, Nowicki R, Biernat W.

J Dtsch Dermatol Ges. 2017 Mar;15(3):325-326. doi: 10.1111/ddg.12800. Epub 2017 Feb 8. No abstract available.

PMID:
28177590
26.

Comment on "Diffuse TTF-1 expression in a case of Merkel cell carcinoma".

Czapiewski P, Biernat W.

Pol J Pathol. 2016;67(3):300. doi: 10.5114/pjp.2016.63784. No abstract available.

27.

Keratin 7 expression in lymph node metastases but not in the primary tumour correlates with distant metastases and poor prognosis in colon carcinoma.

Czapiewski P, Bobowicz M, Pęksa R, Skrzypski M, Gorczyński A, Szczepańska-Michalska K, Korwat A, Jankowski M, Zegarski W, Szulgo-Paczkowska A, Polec T, Piątek M, Skokowski J, Haybaeck J, Żaczek A, Biernat W.

Pol J Pathol. 2016;67(3):228-234. doi: 10.5114/pjp.2016.63774.

28.

Keratoacanthoma‑like cutaneous metastases as the first presentation of lung cancer.

Sławińska M, Sobjanek M, Biernat W, Nowicki R.

Pol Arch Intern Med. 2017 Jan 31;127(1):66-67. doi: 10.20452/pamw.3916. Epub 2017 Jan 31. No abstract available.

29.

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number.

Szutowicz-Zielińska E, Konopa K, Kowalczyk A, Suszko-Każarnowicz M, Duchnowska R, Szczęsna A, Ratajska M, Sowa A, Limon J, Biernat W, Burzykowski T, Jassem J, Dziadziuszko R.

Oncotarget. 2017 Mar 7;8(10):17270-17278. doi: 10.18632/oncotarget.13793.

30.

Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells.

Piasecka D, Kitowska K, Czaplinska D, Mieczkowski K, Mieszkowska M, Turczyk L, Skladanowski AC, Zaczek AJ, Biernat W, Kordek R, Romanska HM, Sadej R.

Oncotarget. 2016 Dec 27;7(52):86011-86025. doi: 10.18632/oncotarget.13322.

31.

Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.

Duchnowska R, Jarząb M, Żebracka-Gala J, Matkowski R, Kowalczyk A, Radecka B, Kowalska M, Pfeifer A, Foszczyńska-Kłoda M, Musolino A, Czartoryska-Arłukowicz B, Litwiniuk M, Surus-Hyla A, Szabłowska-Siwik S, Karczmarek-Borowska B, Dębska-Szmich S, Głodek-Sutek B, Sosińska-Mielcarek K, Chmielowska E, Kalinka-Warzocha E, Olszewski WP, Patera J, Żawrocki A, Pliszka A, Tyszkiewicz T, Rusinek D, Oczko-Wojciechowska M, Jassem J, Biernat W; Polish Brain Metastasis Consortium.

Clin Breast Cancer. 2017 Apr;17(2):e65-e75. doi: 10.1016/j.clbc.2016.08.008. Epub 2016 Sep 8.

PMID:
27692773
32.

Expression of SOX11, PAX5, TTF-1 and ISL-1 in medulloblastoma.

Czapiewski P, Gorczynski A, Radecka K, Wiewiora C, Haybaeck J, Adam P, Fend F, Zakrzewska M, Zakrzewski K, Liberski PP, Biernat W.

Pathol Res Pract. 2016 Nov;212(11):965-971. doi: 10.1016/j.prp.2016.08.006. Epub 2016 Aug 11.

PMID:
27623204
33.

Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma.

Czapiewski P, Gorczyński A, Haybaeck J, Okoń K, Reszeć J, Skrzypczak W, Dzierżanowski J, Kunc M, Karczewska J, Biernat W.

Pol J Pathol. 2016 Jun;67(2):130-5.

34.

Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer.

Bobowicz M, Skrzypski M, Czapiewski P, Marczyk M, Maciejewska A, Jankowski M, Szulgo-Paczkowska A, Zegarski W, Pawłowski R, Polańska J, Biernat W, Jaśkiewicz J, Jassem J.

Clin Exp Metastasis. 2016 Dec;33(8):765-773. Epub 2016 Aug 2.

35.

Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.

Czaplinska D, Mieczkowski K, Supernat A, Skladanowski AC, Kordek R, Biernat W, Zaczek AJ, Romanska HM, Sadej R.

Tumour Biol. 2016 Oct;37(10):13721-13731. Epub 2016 Jul 30.

36.
37.

TTF-1 and PAX5 Are Frequently Expressed in Combined Merkel Cell Carcinoma.

Czapiewski P, Majewska H, Kutzner H, Kazakov D, Renkielska A, Biernat W.

Am J Dermatopathol. 2016 Jul;38(7):513-6. doi: 10.1097/DAD.0000000000000464.

PMID:
27322785
38.

Rak błony śluzowej trzonu macicy u chorych po przebytej chorobie nowotworowej - aspekty kliniczne i molekularne.

Łapińska-Szumczyk SM, Supernat AM, Żaczek AJ, Majewska H, Gulczyński J, Sawicki S, Biernat W, Wydra D.

Ginekol Pol. 2016;87(2):88-93. doi: 10.17772/gp/60559. No abstract available.

39.

Giant cribriform adenocarcinoma of the tongue showing PRKD3 rearrangement.

Majewska H, Skálová A, Weinreb I, Stodulski D, Hyrcza M, Stankiewicz C, Biernat W.

Pol J Pathol. 2016 Mar;67(1):84-90.

40.

Renal clear cell carcinoma metastasis to salivary glands - a series of 9 cases: clinico-pathological study.

Majewska H, Skálová A, Radecka K, Stodulski D, Hyrcza M, Stankiewicz C, Biernat W.

Pol J Pathol. 2016 Mar;67(1):39-45.

41.

Detection of somatic BRCA1/2 mutations in ovarian cancer - next-generation sequencing analysis of 100 cases.

Koczkowska M, Zuk M, Gorczynski A, Ratajska M, Lewandowska M, Biernat W, Limon J, Wasag B.

Cancer Med. 2016 Jul;5(7):1640-6. doi: 10.1002/cam4.748. Epub 2016 May 11.

42.

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis.

Duchnowska R, Pęksa R, Radecka B, Mandat T, Trojanowski T, Jarosz B, Czartoryska-Arłukowicz B, Olszewski WP, Och W, Kalinka-Warzocha E, Kozłowski W, Kowalczyk A, Loi S, Biernat W, Jassem J; Polish Brain Metastasis Consortium.

Breast Cancer Res. 2016 Apr 27;18(1):43. doi: 10.1186/s13058-016-0702-8.

43.

Histological reclassification of parotid gland carcinomas: importance for clinicians.

Stodulski D, Majewska H, Skálová A, Mikaszewski B, Biernat W, Stankiewicz C.

Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3937-3942. Epub 2016 Apr 21.

44.

Immunohistochemical characterisation of molecular subtypes in endometrial cancer.

Łapińska-Szumczyk SM, Supernat AM, Majewska HI, Gulczyński J, Biernat W, Wydra D, Żaczek AJ.

Int J Clin Exp Med. 2015 Nov 15;8(11):21981-90. eCollection 2015.

45.

Castleman's disease mimicking lymph node metastases in a young woman with laryngeal cancer.

Serkies K, Łazar-Poniatowska M, Seredyńska J, Biernat W, Jassem J.

Contemp Oncol (Pozn). 2016;20(5):421-424. doi: 10.5114/wo.2016.64608. Epub 2016 Dec 20.

46.

Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients.

Duchnowska R, Wysocki PJ, Korski K, Czartoryska-Arłukowicz B, Niwińska A, Orlikowska M, Radecka B, Studziński M, Demlova R, Ziółkowska B, Merdalska M, Hajac Ł, Myśliwiec P, Zuziak D, Dębska-Szmich S, Lang I, Foszczyńska-Kłoda M, Karczmarek-Borowska B, Żawrocki A, Kowalczyk A, Biernat W, Jassem J; Central and East European Oncology Group (CEEOG).

Oncotarget. 2016 Jan 5;7(1):550-64. doi: 10.18632/oncotarget.6375.

47.

CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma.

Czapiewski P, Wełnicka-Jaśkiewicz M, Seroczyńska B, Skokowski J, Sejda A, Szade J, Wiewiora C, Biernat W, Żaczek A.

Pol J Pathol. 2015 Sep;66(3):269-75.

48.

Studies of the effect of grasshopper abdominal secretion on wound healing with the use of murine model.

Buszewska-Forajta M, Siluk D, Daghir-Wojtkowiak E, Sejda A, Staśkowiak D, Biernat W, Kaliszan R.

J Ethnopharmacol. 2015 Dec 24;176:413-23. doi: 10.1016/j.jep.2015.11.004. Epub 2015 Nov 6.

PMID:
26549269
49.

Psoriasis of the lips associated with severe psoriatic arthritis - a case report.

Purzycka-Bohdan D, Szczerkowska-Dobosz A, Biernat W, Jaskiewicz-Nyckowska D, Nowicki R.

J Dtsch Dermatol Ges. 2015 Oct;13(10):1024-5. doi: 10.1111/ddg.12645. No abstract available.

PMID:
26408467
50.

[Psoriasis of the lips associated with severe psoriatic arthritis - a case report].

Purzycka-Bohdan D, Szczerkowska-Dobosz A, Biernat W, Jaskiewicz-Nyckowska D, Nowicki R.

J Dtsch Dermatol Ges. 2015 Oct;13(10):1024-5. doi: 10.1111/ddg.60_12645. German. No abstract available.

PMID:
26408466

Supplemental Content

Loading ...
Support Center